UBS increased its price target for Parsons to $64 from $61 and reiterated its Buy rating following the company's Q3 2026 earnings. This adjustment reflects positive financial reporting, including growth in adjusted earnings and revenue, despite a narrowed revenue guidance for 2026.
UBS updated its outlook on Parsons Corporation after the company's third-quarter 2026 earnings. The firm raised its price target from $61 to $64 and reaffirmed its 'Buy' rating, indicating a positive sentiment towards the company's performance. This adjustment was driven by growth in adjusted earnings and revenue, although the company did narrow its 2026 revenue guidance. For traders, this signals a moderately positive short-term outlook for Parsons, as an analyst upgrade often provides a small boost to investor confidence. The long-term implications depend on Parsons' continued execution and future financial reporting, but the maintained 'Buy' rating suggests ongoing confidence from UBS.